☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Hospitalization
Amgen's Corlanor (ivabradine) Receives FDA's Approval to Reduce Risk of Hospitalization for Worsening Heart Failure in Patients wi...
April 15, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.